Autocrine Motility Factor Receptor (AMFR) (C-Term) Peptide
Quick Overview for Autocrine Motility Factor Receptor (AMFR) (C-Term) Peptide (ABIN8095309)
Target
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- AMFR Peptide - C-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-CDC23 antibody ( ARP43039_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- AMFR (Autocrine Motility Factor Receptor (AMFR))
-
Background
-
Background Information: Autocrine motility factor is a tumor motility-stimulating protein secreted by tumor cells. AMFR is a glycosylated transmembrane protein and a receptor for autocrine motility factor. The receptor, which shows some sequence similarity to tumor protein p53, is localized to the leading and trailing edges of carcinoma cells.The Makorin ring finger protein-1 gene (MKRN1) is a highly transcribed, intron-containing source for a family of intronless mammalian genes encoding a novel class of zinc finger proteins. Phylogenetic analyses indicate that the MKRN1 gene is the ancestral founder of this gene family (Gray et al., 2000).[supplied by OMIM].
Alternative Symbols: GP78, RNF45
-
Molecular Weight
- 66kDa
-
Gene ID
- 267
-
UniProt
- Q9UKV5
Target
-